Dr. Robert A. Sisk is a Board-Certified Diplomate of the American Board of Ophthalmology and a Fellow of the American College of Surgeons. His peers selected him as one of The Best Doctors in America.

Dr. Sisk is actively engaged in clinical research and ophthalmic education. Dr. Sisk is a principal investigator or co-investigator for many FDA-regulated investigational drug trials and studies for identification and treatment of genetic eye diseases. Dr. Sisk performs cell therapy and gene therapy procedures, including the FDA-approved gene therapy, Luxturna®. He is an Associate Professor of the Department of Ophthalmology at the University of Cincinnati, where he educates residents and fellows in vitreoretinal surgery. He is the author of numerous publications in the peer-reviewed ophthalmic literature and presents regularly at international clinical and scientific meetings.

Dr. Sisk serves adults and older children at the CEI offices in Edgewood, Kentucky and Blue Ash, Ohio. He provides care for neonates, infants, and young children at Cincinnati Children’s Hospital, a top 3 hospital nationally, where he is Director of Pediatric Vitreoretinal Surgery and Director of Ophthalmic Genetics. While he routinely manages all forms of medical and surgical diseases of the retina in adults, Dr. Sisk has specialized expertise in pediatric retinal surgery, retinal dystrophies, and retinal electrophysiology.